Speaker illustration

Doctor Jacob Schultz

Aarhus University Hospital, Aarhus (Denmark)

Jacob Schultz graduated from Aarhus University Medical School in 2015 and has since been enrolled as a PhD fellow at the Department of Cardiology, Aarhus University Hospital, Denmark. Jacob Schultz was however already active in research during medical school and has been involved in both basic, experimental and clinical studies. The primary focus of Jacob Schultz is now acute pulmonary embolism. The aim of his PhD is to evaluate novel pharmacological and catheter-based therapies in a porcine model of acute pulmonary embolism.

Terlipressin increases systemic and lowers pulmonary arterial pressure in experimental acute pulmonary embolism

Event: Acute Cardiovascular Care 2019

Topic: Pharmacotherapy

Session: Moderated Poster 2: Pulmonary, general ICU and organization of care

Thumbnail

NO-sGC-cGMP pathway stimulation lowers pulmonary vascular resistance in a porcine model of acute pulmonary embolism

Event: Acute Cardiovascular Care 2018

Topic: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure - Treatment

Session: Young Investigator Awards Abstracts

Thumbnail

A novel experimental in vivo model of acute pulmonary embolism

Event: ESC CONGRESS 2017

Topic: Acute pulmonary embolism

Session: What is new in venous thromboembolism?

Thumbnail

This platform is supported by

logo Novo Nordisk